Boston Scientific To Participate In 35th Annual J.P. Morgan Healthcare Conference

MARLBOROUGH, Mass., Dec. 30, 2016

Mike Mahoney, chairman and chief executive officer, will present at approximately 7:30 a.m. PST. At 8:00 a.m., Mike will be joined by Dan Brennan, executive vice president and chief financial officer, Ian Meredith, AM, Ph.D., global chief medical officer and Susie Lisa, vice president, Investor Relations, in a question-and-answer session with audience members.

A live webcast of the presentation and question-and-answer session will be available on the Investor Relations section of the Boston Scientific website at www.bostonscientific.com/investors. Registration at least 15 minutes prior to the scheduled start time is encouraged to ensure a timely connection.

A replay of the webcast will be accessible at www.bostonscientific.com/investors beginning approximately one hour following the completion of the event.

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

CONTACTS
Media: ARIVA.DE Börsen-Geflüster Kurse Boston Scientific 67,64 $ +0,33%	Investors:
Tom Keppeler	Susie Lisa, CFA
508-683-6585 (office)	508- 683-5565 (office)
Corporate Communications	Investor Relations
Boston Scientific Corporation	Boston Scientific Corporation
tom.keppeler@bsci.com	investor_relations@bsci.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/boston-scientific-to-participate-in-35th-annual-jp-morgan-healthcare-conference-300383826.html

SOURCE Boston Scientific Corporation